British drugmaker AstraZeneca said on Saturday its vaccine developed with the University of Oxford appeared to offer only limited protection against mild disease caused by the South African variant...
from NDTV News - Topstories https://ift.tt/3aCYrCE
https://ift.tt/eA8V8J
Saturday, February 6, 2021
Home »
» Oxford Covid Vaccine Less Effective Against South African Variant: Study
0 comments:
Post a Comment